Max Healthcare Institute Ltd is a leading healthcare provider in India, offering a wide range of medical services through its extensive network of hospitals and healthcare facilities. Known for its state-of-the-art medical technology, skilled professionals, and a patient-centric approach, the company excels in specialties such as cardiology, oncology, neurology, and orthopedics. As of January 18, 2025, the Max Healthcare share price on the NSE stands at ₹1,026.00 INR. Below is an overview of the company’s share price targets for 2025, as well as projections for 2026 to 2030.
Max Healthcare Share Price Target Tomorrow 2025, 2026, 2027, 2028, 2029 To 2030
Max Healthcare Share Price Target Tomorrow 2025 ₹1,240, 2026 ₹1,560, 2027 ₹1,876, 2028 ₹2,190, 2029 ₹2,535 To 2030 ₹2,865. Max Healthcare Institute Limited is an Indian for-profit private hospital chain headquartered in Delhi. As of 2024, Max Healthcare operates 19 hospitals with more than 4,000 beds, primarily in North India. Max Healthcare also operates the Max Lab pathology and Max@Home home medical services divisions.
- Stock price: MAXHEALTH (NSE) ₹1,026.00 -23.95 (-2.28%)
- Headquarters: New Delhi
- Founder: Analjit Singh
- Subsidiaries: Max Lab, Crosslay Remedies Limited · See more
- Founded: 2001
- Number of employees: 15,000 (2023)
Max Healthcare Share Price Target 2025 To 2030
| Year | Expected Share Price Target (INR) |
|---|
| 2025 | ₹1,240 |
| 2026 | ₹1,560 |
| 2027 | ₹1,876 |
| 2028 | ₹2,190 |
| 2029 | ₹2,535 |
| 2030 | ₹2,865 |
| Category | Stock Market |
Max Healthcare Institute Ltd: Market Overview
| Metric | Value |
|---|
| Opening Price | ₹1,051.25 |
| Highest Price | ₹1,056.45 |
| Lowest Price | ₹1,008.70 |
| Previous Close | ₹1,049.95 |
| Volume | 2,750,545 |
| Value (Lacs) | ₹28,238.47 |
| VWAP | ₹1,026.68 |
| Upper Circuit Limit | ₹1,154.90 |
| Lower Circuit Limit | ₹944.95 |
| 52-Week High | ₹1,227.95 |
| 52-Week Low | ₹694.80 |
| Market Capitalization | ₹99,803 Crore |
| Face Value | ₹10 |
Key Drivers for Max Healthcare Share Price Target 2025: ₹1,240
- Expansion of Healthcare Infrastructure: The company’s efforts to expand its network, especially in underserved areas, will likely drive revenue growth and increase patient inflow.
- Rising Demand for Quality Healthcare: As health awareness rises and India’s middle class grows, more people are likely to seek high-quality healthcare services, benefiting Max Healthcare.
- Focus on Specialized Treatments: Max Healthcare’s emphasis on high-margin specialties like oncology, cardiology, and organ transplants can enhance profitability by attracting patients seeking advanced care.
- Growth in Medical Tourism: India’s reputation for offering affordable, high-quality medical treatments may boost Max Healthcare’s international patient base, contributing to its global expansion.
Max Healthcare Share Price Target 2026
| Year | Share Price Target (INR) |
| 2026 | ₹1,560 |
Max Healthcare Share Price Target 2027
| Year | Share Price Target (INR) |
| 2027 | ₹1,876 |
Max Healthcare Share Price Target 2028
| Year | Share Price Target (INR) |
| 2028 | ₹2,190 |
Max Healthcare Share Price Target 2029
| Year | Share Price Target (INR) |
| 2029 | ₹2,535 |
Potential Risks for Max Healthcare Share Price Target 2030: ₹2,865
- Regulatory and Policy Risks: Changes in government healthcare policies or new pricing and compliance regulations could negatively affect Max Healthcare’s profitability and operational flexibility.
- Intense Competition: The healthcare sector is highly competitive, and both established players and new entrants could impact Max Healthcare’s market share and margins.
- Rising Operational Costs: As costs for medical technology, skilled professionals, and facility maintenance rise, managing these costs efficiently will be crucial to maintaining profit margins.
- Economic and Global Health Crises: Economic downturns or global health emergencies, such as pandemics, could disrupt patient inflow, supply chains, and medical tourism, potentially impacting revenue.
Max Healthcare Institute Ltd: Shareholding Pattern
| Shareholder Category | Percentage Holding |
|---|
| Promoters | 23.74% |
| Foreign Institutional Investors (FII) | 57.29% |
| Domestic Institutional Investors (DII) | 15.14% |
| Public | 3.83% |
Max Healthcare Financials
| Financial Metric | Value (INR) | Y/Y Change |
|---|
| Revenue | ₹54.06 Billion | +18.49% |
| Operating Expense | ₹20.78 Billion | +14.97% |
| Net Income | ₹10.58 Billion | -4.16% |
| Net Profit Margin | 19.56% | -19.14% |
| Earnings Per Share | ₹10.84 | -4.58% |
| EBITDA | ₹14.82 Billion | +21.21% |
| Effective Tax Rate | 22.54% | — |
What is Max Healthcare famous for?
As a regional hub for complex medical procedures, Max Smart Super Speciality Hospital, Saket, is renowned for its expertise in neurovascular interventions, targeted cancer treatments, heart surgeries, orthopaedic surgeries, and a wide range of renal, bariatric, paediatric, obstetric, and gynaecological treatments.
Who is the CFO of Max Healthcare?
Yogesh Sareen is the Chief Financial Officer (CFO) of Max Healthcare. He is also a Senior Director at the hospital chain.
Who is the owner of Max?
Analjit Singh is the founder and chairman of the Max Group, an Indian multi-business enterprise. The Max Group has interests in real estate, life insurance, and senior care.
How much is max a month?
Max subscription plans
| Package | Price |
| Max With Ads | $9.99 per month / $99.99 per year |
| Max Ad-Free | $15.99 per month / $149.99 per year |
| Max Ultimate Ad-Free | $19.99 per month / $199.99 per year |
